Over the past a long time, the volume of patients referred for allogeneic hematopoietic cell transplantation has dropped substantially,133 but the procedure should be proposed to younger/in good shape sufferers in whom BCR/BCL2 inhibitor therapy fails, specifically in those with TP53Di sini, BP77 berkomitmen untuk memberikan pengalaman yang melebih